Poolman et al., 1983, Infect. Immun. 40:398-406. |
Strittmatter et al. 1985, J. Experim. 164:2038-2048. |
Frasch et al., “Serotype Antigens of Neisseria Meningitidis and A Proposed Scheme For Designation of Serotypes”, Review of Infections Diseases, vol. 7(4):504-510, (1985). |
Reingold et al., “Age-Specific Differences In Duration Of Clinical Protection After Vaccination With Menningococcal Menningococcal Polysaccharide A Vaccine”, The Lancet, pp. 114-118, (1985). |
Zollinger, “New And Improved Vaccines Against Meningococcal Diseases”, pp. 325-348, (1990). |
Frasch, “Status Of A Group B Neisseria Meningitidis Vaccine” Eur. J. Clin. Microbiol., vol. 4(6):533-536, (1985). |
Frasch et al., “Immune Responses Of Adults and Children To Group B Neisseria Meningitidis Outer Membrane Protein Vaccines”, Bacterial Vaccines, pp. 262-272. |
Frasch et al. “Antibody Response of Adults To An Aluminum Hydroxide-Adsorbed Neisseria Meningitidis Serotype 2b Protein-Group B. Polysaccharide Vaccine”, The Journal Of Infectious Diseases, vol. 158(4):710-718, (1988). |
Moreno et al., “Immunity And Protection Of Mice Against Neisseria Meningitidis Group B By Vaccination, Using Polysaccharide Complexed With Outer Membrane Proteins: A Comparison With Purified B Polysaccharide” Infection And Immunity, vol. 47(2):527-533, (1985). |
Rosenzvist et al., “Antibody Responses To Serogroup B Meninococcal Outer Membrane Antigens After Vaccination And Infection”, Journal Of Clinical Microbiology, vol. 26(8):1543-1548, (1988). |
Wedege et al., “Human Antibody Response To A Group B Serotype 2a Meningococcal Vaccine Determined By Immunoblotting”, Infection And Immunity, vol. 51(2):571-578, (1986). |
Wedege et al., “Human Immunoglobulin G Subclass Immune Response To Outer Membrane Antigens In Meningococcal Group B Vaccine”, Journal Of Clinical Microbiology, vol. 25(8):1349-1353, (1987). |
Zollinger et al., “Complex Of Meningococcal Group B Polysaccharide and Type 2 Outer Membrane Protein Immunogenic In Man” The Journal Of Clinical Investigation, vol. 63:836-848, (1979). |
Frasch, “Vaccines For Prevention Of Meningococcal Disease”, Clinical Microbiology Review, vol. 2:S134-S138, (1989). |
Munkley et al., “Blocking Of Bacericidal Killing Of Neisseria Meningitidis By Antibodies Directed Against Class 4 Outer Membrane Protein”, Microbial Pathogenesis, vol. 11:447-452, (1991). |
Woods et al., “Resistance to Meningococcemia Apparently Conferred by Anti-H.8 Monoclonal Antibody is Due To Contaminating Endotoxin And Not To Specific Immunoprotection”, Infection And Immunity, vol. 55(8):1927-1928, (1987). |
Nicholson et al., “Outer Membrane Proteins Of Three Pathogenic Leptospira Species”, Veterinary Microbiology, vol. 36:123-138, (1993). |
Butler et al., “Identification And Characterization Of Proteinase K-Resistant Proteins In Members Of The Class Mollicutes”, Infection And Immunity, vol. 59(3):1037-1042, (1991). |
Bastian et al., “Antiserum To Scrapie-Associated Fibril Protein Cross-Reacts With Spiroplasma Mirum Fibril Proteins”, Journal of Clinical Microbiology, vol. 25(12):2430-2431, (1987). |
Prusiner et al., “Attempts To Restore Scrapie Prion Infectivity After Exposure To Protein Denaturants”, Proc. Natl. Acad. Sci. USA, vol. 90:2793-2797, (1993). |
Onodera et al., “Isolation Of Scrapie Agent From The Placenta Of Sheep With Natural Scrapie In Japan”, Microbiol. Immunol. vol. 37(4):311-316, (1993). |
Brodeur et al., “Protein Against Infection With Neisseria Meningitidis Group B Serotype 2b By Passive Immunization With Serotype-Specific Monoclonal Antibody” Infection And Immunity, vol. 50(2):510-516, (1985). |
Martin et al., “Immunological Characterization Of The Lipooligosaccharide B Band Of Bordetella Pertussis”, Infection and Immunity, vol. 60:(7):2718-2725, (1992). |
Lussier et al., “Detection of Neisseria Gonorrhoeae By Dot-Enzyme Immunoassay Using Monoclonal Antibodies”, Journal of Immunoassay, vol. 10(4):373-394, (1989). |
Brodeur et al., “Mouse Models Of Infection For Neisseria Meningitidis B,2b And Haemophilus Influenzae Type b Diseases”, Can. J. Microbiol., vol. 32:33-37, (1986). |
Wang et al., “Clonal And Antigenic Analysis Of Serogroup A Neisseria Meningitidis With Particular Reference To Epidemiological Features Of Epidemic Meningitis In The People's Republic of China”, Infection And Immunity, vol. 60(12):5267-5282, (1992). |
Martin et al., “Mapping Of B-Cell Epitopes On The Outer Membrane P2 Porin Protein Of Haemophilus Influenzae By Using Recombinant Proteins And Synthetic Peptides” Infection and Immunity, vol. 59(4):1457-1464, (1991). |
Kupsch et al., “Variable Opacity (Opa) Outer Membrane Proteins Account For The Cell Tropisms Displayed By Neisseria Gonorrhoeae For Human Leukocytes And Epithelial Cells”, The EMBO Journal, vol. 12(2):641-650, (1993). |
Bhat et al., “The Opacity Proteins Of Neisseria Gonorrhoeae Strain MS11 Are Encoded By A Family Of 11 Complete Genes”, Molecular Microbiology, vol. 6(8):1073-1076, (1992). |
Bhat et al., “The Opacity Proteins Of Neisseria Gonorrhoeae Strain MS11 Are Encoded By A Family Of 11 Complete Genes”, Molecular Microbiology, vol. 5(8):1889-1901, (1991). |
Wolff et al. “Identification and Characterization of Specific Sequences Encoding Pathogenicity Associated Proteins in the Genome of Commensal Neisseria Species” FEMS Microbiology Letters 125: 255-264 (1995). |
Sacchi et al. “Considerations on the Use of Neisseria Meningitidis Class 5 Proteins As Meningococcal BC Vaccine Components” Vaccine 13: 112-118 (1995). |
Strittmatter et al. “Isolation and Preliminary Biochemical Characterization of the Gonococcal H.8 Antigen” Journal of Experimental Medicine164: 2038-2048 (Dec. 1986). |